Sign Up to like & get
recommendations!
1
Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15060668
Abstract: The identification and removal of all gross and microscopic tumor to render the patient disease free represents a huge challenge in ovarian cancer treatment. The presence of residual disease is an independent negative prognostic factor.…
read more here.
Keywords:
fluorochrome selection;
ovarian cancer;
intraoperative ovarian;
imaging intraoperative ... See more keywords